December 16, 2021: Today we are publishing the third in Whistleblowing Canada’s series of six monthly policy briefs on whistleblowing and drug safety. Learn why it became necessary to blow the whistle in this case which challenged Health Canada's drug approval process in the 1990’s. When laws are not upheld and whistleblowers ignored, the consequences are serious, far-reaching, and lasting into the present. Learn about how there are little options for honest people who want to do the right thing when there is top-down unethicality in an organization and what can be done about such a situation.

Listen to the trailer

 Read the Policy Brief


View Our Webinars and Panel Discussions

July 30, 2021

Panel Discussion: International Whistleblowing - Challenges and Opportunities
During National Whistleblower Appreciation Day in the United States - Moderated by Mark Worth

- with Pamela Forward, Gilbert Sendugwa, and Darko Ivanovitch

May 12, 2021  

Whistleblowing: Necessary to Democratic Governance

- by Edgar Schmidt 

April 14, 2021

Canada's Failed Whistleblower Protection Law Comes Last. 

- by Tom Devine

March 17, 2021  

Expansion of Whistleblower Reward Programs in the US, Canada and Globally 

-by Mary Inman

Feb. 10, 2021

Organizational Culture and Whistleblowing. The invisible forces driving reprisals.

by Pamela Forward


Learn About Key Issues


Dysfunctional Organizational Cultures

Weak Whistleblower Protection Legislation

Weak Whistleblower Protection Legislation

Oversight Mechanisms

Oversight Mechanisms


How You Can Help:

Volunteer       Donate       Get Updates